Peter Hovstadius

Dr. Peter Hovstadius has built a successful career in Life Science and business development, focusing on improving health outcomes through innovative medicines, digital health, and data-driven decisions. With a background in Medicine and a Ph.D. in Drug Development from Uppsala University, Sweden, he is well-equipped to navigate the complexities of healthcare innovation and leadership.

Apart from his academic achievements, Dr. Hovstadius has held key roles in various organizations, including CEO at Hovstadius Consulting, Chief Innovation Officer at Novartis, and Chief Scientific Officer at Merck Sharp & Dohme. His expertise spans across clinical pharmacology, medical affairs, and research management.

Driven by a passion for exploring new frontiers, Dr. Hovstadius is deeply interested in the convergence of Innovation, exponential tech, futurism, and healthcare. His versatile background in engineering physics, mathematics, and medicine allows him to approach challenges with a unique perspective and drive impactful change.

Throughout his career, Dr. Hovstadius has demonstrated a commitment to good leadership practices and fostering innovation within the healthcare industry. He values collaboration and continuous learning, making meaningful connections with people to exchange stories and insights.

With a wealth of professional experiences, from board memberships to executive leadership roles, Dr. Hovstadius has honed his skills in strategic decision-making, business growth, and clinical development. His journey from academia to industry showcases his multifaceted expertise and dedication to shaping the future of healthcare.